Thrivent Financial for Lutherans’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-38,886
| Closed | -$3.86M | – | 2306 |
|
|
2019
Q3 | $3.86M | Buy |
38,886
+257
| +0.7% | +$24.4K | 0.01% | 744 |
|
|
2019
Q2 | $3.57M | Buy |
38,629
+935
| +2% | +$88.8K | 0.01% | 769 |
|
|
2019
Q1 | $3.56M | Sell |
37,694
-23,200
| -38% | -$2.03M | 0.01% | 764 |
|
|
2018
Q4 | $4.06M | Sell |
60,894
-693,729
| -92% | -$51.2M | 0.01% | 659 |
|
|
2018
Q3 | $67.5M | Sell |
754,623
-73,850
| -9% | -$6.53M | 0.21% | 112 |
|
|
2018
Q2 | $65.8M | Sell |
828,473
-719,149
| -46% | -$59.7M | 0.21% | 113 |
|
|
2018
Q1 | $138M | Sell |
1,547,622
-88,045
| -5% | -$8.45M | 0.47% | 48 |
|
|
2017
Q4 | $171M | Buy |
1,635,667
+423,509
| +35% | +$47.8M | 0.57% | 34 |
|
|
2017
Q3 | $177M | Sell |
1,212,158
-106,957
| -8% | -$14.6M | 0.62% | 31 |
|
|
2017
Q2 | $171M | Buy |
1,319,115
+124,915
| +10% | +$15.3M | 0.71% | 26 |
|
|
2017
Q1 | $149M | Sell |
1,194,200
-332,650
| -22% | -$39.8M | 0.64% | 28 |
|
|
2016
Q4 | $177M | Buy |
1,526,850
+152,924
| +11% | +$17M | 0.79% | 19 |
|
|
2016
Q3 | $144M | Buy |
1,373,926
+291,225
| +27% | +$31.5M | 0.66% | 26 |
|
|
2016
Q2 | $107M | Buy |
1,082,701
+1,053,816
| +3,648% | +$109M | 0.51% | 39 |
|
|
2016
Q1 | $2.93M | Sell |
28,885
-230
| -0.8% | -$23.7K | 0.01% | 761 |
|
|
2015
Q4 | $3.49M | Buy |
29,115
+7,465
| +34% | +$864K | 0.02% | 697 |
|
|
2015
Q3 | $2.34M | Sell |
21,650
-6,014
| -22% | -$746K | 0.01% | 752 |
|
|
2015
Q2 | $3.2M | Buy |
27,664
+987
| +4% | +$113K | 0.02% | 572 |
|
|
2015
Q1 | $3.07M | Buy |
26,677
+577
| +2% | +$68.9K | 0.02% | 594 |
|
|
2014
Q4 | $2.94M | Buy |
26,100
+2,535
| +11% | +$267K | 0.02% | 603 |
|
|
2014
Q3 | $2.23M | Sell |
23,565
-15
| -0.1% | -$1.35K | 0.01% | 655 |
|
|
2014
Q2 | $2.02M | Sell |
23,580
-12,930
| -35% | -$983K | 0.01% | 702 |
|
|
2014
Q1 | $2.55M | Buy |
36,510
+12,600
| +53% | +$998K | 0.02% | 542 |
|
|
2013
Q4 | $2.02M | Sell |
23,910
-20
| -0.1% | -$1.58K | 0.01% | 603 |
|
|
2013
Q3 | $1.84M | Sell |
23,930
-237,470
| -91% | -$16.6M | 0.01% | 601 |
|
|
2013
Q2 | $15.3K | Buy |
+261,400
| New | +$15.7M | 0.1% | 218 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Thrivent Financial for Lutherans's CELG Position: Q4 2019 in Review
Thrivent Financial for Lutherans sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 38,886 shares — an estimated $3.86M sold.
Thrivent Financial for Lutherans first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $177M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Thrivent Financial for Lutherans reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Thrivent Financial for Lutherans sold 38,886 Celgene Corp shares in Q4 2019, an estimated $3.86M.
- Thrivent Financial for Lutherans first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Thrivent Financial for Lutherans's Celgene Corp position peaked at $177M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Thrivent Financial for Lutherans's 13F filing for Q4 2019, filed 13 Feb 2020.